Na Hyun Kim
Overview
Explore the profile of Na Hyun Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
424
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
PD-1 transcriptomic landscape across cancers and implications for immune checkpoint blockade outcome
Chen H, Kim N, Nishizaki D, Nesline M, Conroy J, DePietro P, et al.
NPJ Genom Med
. 2025 Mar;
10(1):21.
PMID: 40069238
Programmed cell death protein 1 (PD-1) is a critical immune checkpoint receptor and a target for cancer immune checkpoint inhibitors (ICI). We investigated PD-1 transcript expression across cancer types and...
2.
Prognostic Impact of Primary Tumor Size in Papillary Thyroid Carcinoma without Lymph Node Metastasis
Kim C, Kim H, Kim N, Kim T, Kim W, Chung J, et al.
Endocrinol Metab (Seoul)
. 2025 Feb;
PMID: 39999852
Background: We aimed to investigate the prognostic significance of primary tumor size in patients with pT1-T3a N0 M0 papillary thyroid carcinoma (PTC), minimizing the impact of confounding factors. Methods: A...
3.
Kim N, Kim C, Chung S, Chung K, Kim W, Jeon M
JCEM Case Rep
. 2024 Nov;
2(12):luae208.
PMID: 39526029
Parathyroid carcinoma is a rare endocrine malignancy for which the primary treatment is surgery; however, 50% of the patients develop local recurrence or distant metastases. No consensus exists on the...
4.
Kim N, Hamadani M, Abedin S
Expert Opin Investig Drugs
. 2024 Jul;
33(8):791-799.
PMID: 38973782
Introduction: Steroid-refractory acute graft-versus-host disease (SR-aGVHD) remains a formidable obstacle in the field of allogeneic hematopoietic cell transplantation (allo-HCT), significantly contributing to patient morbidity and mortality. The current therapeutic landscape...
5.
Cho S, Yoo M, Kim N, Paik S, Won D, Han J, et al.
Korean J Fam Med
. 2024 Jun;
PMID: 38872408
Background: The relationship between weight change and quality of life remains controversial. This study aimed to investigate whether changes in body weight among participants in different baseline body mass index...
6.
Kim N, Kim M, Han J, Sohn H, Oh B, Lee J, et al.
Digit Health
. 2024 May;
10:20552076241257046.
PMID: 38784054
Objective: Depression among non-smokers at risk of second-hand smoke (SHS) exposure has been a neglected public health concern despite their vulnerability. The objective of this study was to develop high-performance...
7.
Patel S, Armbruster H, Pardo G, Archambeau B, Kim N, Jeter J, et al.
PLoS One
. 2024 Apr;
19(4):e0297531.
PMID: 38687774
Basal cell carcinoma (BCC) is highly curable by surgical excision or radiation. In rare cases, BCC can be locally destructive or difficult to surgically remove. Hedgehog inhibition (HHI) with vismodegib...
8.
Chung C, Park S, Huh J, Kim N, Shon C, Oh E, et al.
J Inflamm (Lond)
. 2024 Apr;
21(1):13.
PMID: 38654364
Background: Exposure to noxious particles, including cigarette smoke and fine particulate matter (PM), is a risk factor for chronic obstructive pulmonary disease (COPD) and promotes inflammation and cell death in...
9.
Kim N, Gim Y, Choi K, Suh W, Jun R, Han K
BMC Ophthalmol
. 2023 Nov;
23(1):482.
PMID: 38001418
Background: To compare the accuracy of nine intraocular lens (IOL) power calculation formulas, including three traditional formulas (SRK/T, Haigis, and Hoffer Q) and six new-generation formulas (Barrett Universal II [BUII],...
10.
Kim N, Kim H, Cho S, Han K
Korean J Ophthalmol
. 2023 Oct;
37(6):510-517.
PMID: 37899279
Purpose: To evaluate repeatability and agreement of chord mu between Scheimpflug tomography (Pentacam HR) and sweptsource optical coherence tomography-based optical biometer (IOLMaster 700). Methods: In this retrospective study, 63 eyes...